Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review

There is mounting evidence that pulmonary arterial hypertension (PAH), asthma and chronic obstructive pulmonary disease (COPD) share important pathological features, including inflammation, smooth muscle contraction and remodeling. No existing drug provides the combined potential advantages of reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dongmei, Lee, Dongwon, Sung, Yong Kiel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090995/
https://www.ncbi.nlm.nih.gov/pubmed/21477377
http://dx.doi.org/10.1186/1465-9921-12-45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090995/
https://www.ncbi.nlm.nih.gov/pubmed/21477377
http://dx.doi.org/10.1186/1465-9921-12-45

Ejemplares similares